...
首页> 外文期刊>Journal of Clinical Microbiology >Evaluation of an Enzyme Immunoassay Technique for Detection of Antibodies against Treponema pallidum
【24h】

Evaluation of an Enzyme Immunoassay Technique for Detection of Antibodies against Treponema pallidum

机译:酶免疫法检测梅毒螺旋体抗体的评价

获取原文
           

摘要

In the present study, the performance of an enzyme-linked immunosorbent assay (ELISA) technique (Eti-syphilis-G and Eti-syphilis-M; DiaSorin) for detection of Treponema pallidum immunoglobulin M (IgM) and IgG antibodies for the laboratory diagnosis of syphilis was evaluated. Four hundred forty-one samples were studied. The sensitivity and specificity of the ELISA were 100 and 93%, respectively, compared with the results of a microhemagglutination assay for Treponema pallidum (MHA-TP) and 99.4 and 100%, respectively, compared with the results of the fluorescent treponemal antibody absorption (FTA-Abs) test. The results of the ELISA technique were concordant with those of MHA-TP for 98% of the samples tested, while the rate of concordance with the FTA-Abs test was 99.5%. The sensitivities of the rapid plasma reagin (RPR) test, MHA-TP, and the ELISA in the different phases of syphilis compared with the results of the FTA-Abs test were 92, 88, and 100%, respectively, for patients with primary syphilis; 100% for all tests evaluated for patients with secondary syphilis; 97.2, 99.4, and 100%, respectively, for patients with latent syphilis; and 57.9, 92.6, and 97.9%, respectively, for patients with past treated syphilis. The RPR test was reactive with 12 samples that were negative by all the specific tests. IgM antibodies were most frequently detected by the ELISA for IgM antibodies (32.8%) than by the FTA-Abs for IgM antibodies (28.4%). Detection of these antibodies by the FTA-Abs test and the ELISA for IgM antibodies decreased with the stage of disease (72 and 88%, respectively, for patients with primary syphilis to 17 and 19%, respectively, for patients with early latent syphilis). The high sensitivity and specificity of this ELISA technique during all stages of syphilis, together with the fact that it is a simple, objective, and easily automated method, lead us to believe that it could be used as a screening test for syphilis.
机译:在本研究中,酶联免疫吸附测定(ELISA)技术(Eti-syphilis-G和Eti-syphilis-M; DiaSorin)用于检测梅毒螺旋体免疫球蛋白M(IgM)的性能评估了用于梅毒实验室诊断的IgG抗体。研究了414个样本。酶联免疫吸附试验的敏感性和特异性分别为梅毒螺旋体(MHA-TP)微血凝试验的结果和分别的99.4和100%,分别为100%和93%荧光性视网膜蛋白抗体吸收(FTA-Abs)测试的结果。 ELISA技术的结果与98%的样本的MHA-TP一致,而与FTA-Abs的一致性为99.5%。与FTA-Abs测试结果相比,梅毒不同阶段的快速血浆反应素(RPR)测试,MHA-TP和ELISA的敏感性分别为92%,88%和100%梅毒;对于所有评估为继发性梅毒患者的测试,100%;梅毒潜伏者分别为97.2、99.4和100%;过去接受过梅毒治疗的患者分别为57.9%,92.6%和97.9%。 RPR测试对所有特定测试均为阴性的12个样品具有反应性。 ELISA检测IgM抗体的频率最高(32.8%),而FTA-Abs检测IgM抗体的频率最高(28.4%)。通过FTA-Abs测试和ELISA的IgM抗体检测这些抗体随着疾病的进展而降低(原发性梅毒患者分别为72%和88%,早期潜伏梅毒患者分别为17%和19%) 。这种ELISA技术在梅毒的所有阶段都具有很高的灵敏度和特异性,并且它是一种简单,客观且易于自动化的方法,这一事实使我们相信它可以用作梅毒的筛查试验。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号